BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19819314)

  • 1. Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents.
    Muela S; Escalera B; Peña MA; Bustamante P
    Int J Pharm; 2010 Jan; 384(1-2):93-9. PubMed ID: 19819314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility parameter of drugs for predicting the solubility profile type within a wide polarity range in solvent mixtures.
    Peña MA; Reíllo A; Escalera B; Bustamante P
    Int J Pharm; 2006 Sep; 321(1-2):155-61. PubMed ID: 16828993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility behavior and prediction for antihelmintics at several temperatures in aqueous and nonaqueous mixtures.
    Bustamante P; Muela S; Escalera B; Peña A
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):644-9. PubMed ID: 20460790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamics of cosolvent action: phenacetin, salicylic acid and probenecid.
    Peña MA; Escalera B; Reíllo A; Sánchez AB; Bustamante P
    J Pharm Sci; 2009 Mar; 98(3):1129-35. PubMed ID: 18661534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of solvent composition on the solid phase at equilibrium with saturated solutions of quinolones in different solvent mixtures.
    Romero S; Bustamante P; Escalera B; Mura P; Cirri M
    J Pharm Biomed Anal; 2004 Jun; 35(4):715-26. PubMed ID: 15193716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions.
    Unga J; Tajarobi F; Norder O; Frenning G; Larsson A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico prediction of drug solubility in water-ethanol mixtures using Jouyban-Acree model.
    Jouyban A; Acree WE
    J Pharm Pharm Sci; 2006; 9(2):262-9. PubMed ID: 16959195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-solvent solubilization of some poorly-soluble antidiabetic drugs.
    Seedher N; Kanojia M
    Pharm Dev Technol; 2009; 14(2):185-92. PubMed ID: 19519190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2005 Oct; 303(1-2):54-61. PubMed ID: 16105723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of solid dispersion technique combination on dissolution of tanshinone IIA].
    Yuan J; Mao S; Shen Q; Hou S; He Y
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):685-9. PubMed ID: 19624004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cosolvency model to predict solubility of drugs at several temperatures from a limited number of solubility measurements.
    Jouyban A; Romero S; Chan HK; Clark BJ; Bustamante P
    Chem Pharm Bull (Tokyo); 2002 May; 50(5):594-9. PubMed ID: 12036011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling.
    Mota FL; Carneiro AP; Queimada AJ; Pinho SP; Macedo EA
    Eur J Pharm Sci; 2009 Jun; 37(3-4):499-507. PubMed ID: 19406228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.